{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:06:01Z","timestamp":1755695161867,"version":"3.37.3"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211094","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:39:03Z","timestamp":1548275943000},"page":"e0211094","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["The use of initial dosing of gentamicin in the management of pyelonephritis\/urosepsis: A retrospective study"],"prefix":"10.1371","volume":"14","author":[{"given":"Silvia","family":"Ryanto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Czarniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Travers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-995X","authenticated-orcid":true,"given":"Bruce","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QCO.0000000000000228","article-title":"Global epidemiology of urinary tract infections","volume":"29","author":"Z Tandogdu","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.eururo.2006.08.012","article-title":"Prevalence of Hospital-Acquired Urinary tract infection in urology departments","volume":"51","author":"T Johansen","year":"2007","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMcp1104429","article-title":"Uncomplicated urinary tract infection","volume":"366","author":"T. Hooton","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"K Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref5","first-page":"333","article-title":"Urinary tract infections: contemporary management","volume":"28","author":"D. Rahn","year":"2008","journal-title":"Urol Nurs"},{"key":"ref6","first-page":"209","article-title":"Urinary tract infections: self-reported incidence and associated costs","volume":"10","author":"B Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"B. Foxman","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2362.2008.02008.x","article-title":"Therapeutic challenges of urosepsis","volume":"38","author":"F Wagenlehner","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-200118040-00002","article-title":"A practical approach to the management of complicated urinary tract infection","volume":"18","author":"L. Nicolle","year":"2001","journal-title":"Drugs and Aging"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"45","author":"C Czaja","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/520138","article-title":"Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis","volume":"29","author":"R Echols","year":"1999","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0749-0704(05)70106-8","article-title":"Severe sepsis and septic shock. Definitions, epidemology, and clinical manifestations","volume":"16","author":"R. Balk","year":"2000","journal-title":"Crit Care Clin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"R Bone","year":"1992","journal-title":"Chest"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s001340051121","article-title":"The epidemiology of the systemic inflammatory response","volume":"26","author":"C. Brun-Buisson","year":"2000","journal-title":"Intensive Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/j.1875-9114.1988.tb04092.x","article-title":"Aminoglycosides: Current role in antimicrobial therapy","volume":"8","author":"B. Cunha","year":"1988","journal-title":"Pharmacotherapy"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"R Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2005-921227","article-title":"Epidemiology, economy and practice\u2013results of the German study on prevalence by the competence network sepsis (Sep-Net)","volume":"41","author":"F Brunkhorst","year":"2006","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"G Martin","year":"2003","journal-title":"N Engl J"},{"key":"ref19","first-page":"1589","article-title":"Gram-negative bacteremia. III. Reassessment of eitology, epidemiology and ecology 612 patients","volume":"68","author":"B Kreger","year":"1980","journal-title":"Am J Med"},{"key":"ref20","first-page":"344","article-title":"Gram-negative bacteremia. Re-evaluation of clinical features and IV treatment in 612 patients","volume":"68","author":"B Kreger","year":"1980","journal-title":"Am J Med"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijantimicag.2007.06.027","article-title":"Optimal management of urosepsis from the urological perspective","volume":"30","author":"F Wagenlehner","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0891-8422(23)00528-1","article-title":"Aminoglycosides, imipenem, and aztreonam","volume":"9","author":"J Johnson","year":"1992","journal-title":"Clin Podiatr Med Surg"},{"key":"ref23","unstructured":"Antibiotic. In: eTG complete. Melbourne: Therapeutic Guidelines Limited; [cited 23\/10\/2014]."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhealeco.2014.06.006","article-title":"Hips and hearts: The variation in incentive effects of insurance across hospital procedures","volume":"37","author":"D Doiron","year":"2014","journal-title":"J Health Econ"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"T. Hooton","year":"2012","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1093\/infdis\/124.Supplement_1.S180","article-title":"Gentamicin and kanamycin in the treatment of Gram-negative sepsis: A comparative study","volume":"124","author":"W Holloway","year":"1971","journal-title":"J Infec Diseases"},{"key":"ref27","first-page":"122","article-title":"Gentamicin: clinical and pharmacological studies","volume":"3","author":"W. Holloway","year":"1970","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2672.2006.02812.x","article-title":"Antimicrobial resistance in bacteria isolated from aquaculture sources","volume":"100","author":"O Akinbowale","year":"2006","journal-title":"Australia Journal Of Applied Microbiology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ageing\/afu023","article-title":"Aminoglycosides use in patients over 75 years old","volume":"43","author":"T Fraisse","year":"2014","journal-title":"Age and Aging"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/IDR.S27965","article-title":"Evaluation og the use of piperacillin\/tazobactam (Tazocin) at Hamad General Hospital, Qatar: are there unjustified prescriptions?","volume":"5","author":"F Khan","year":"2012","journal-title":"Infection and Drug Resistance"},{"key":"ref31","first-page":"385","article-title":"Aminoglycosides: A reassessment of their therapeutic role","volume":"7","author":"S. Barriere","year":"1988","journal-title":"Clin Pharm"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00003088-199427050-00005","article-title":"Pharmacokinetic contributions to post-antibiotic effects","volume":"27","author":"G Zhanel","year":"1994","journal-title":"Clin Pharmacokinetics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jinf.2010.10.009","article-title":"Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis","volume":"62","author":"SS Lee","year":"2011","journal-title":"J of Infection"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T08:23:20Z","timestamp":1720945400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211094"}},"subtitle":[],"editor":[{"given":"Baochuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211094","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,1,23]]}}}